Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -70.54 Billion JPY | 26.08% |
| 2022 | -95.44 Billion JPY | -1.11% |
| 2021 | -94.39 Billion JPY | -21.7% |
| 2020 | -77.56 Billion JPY | -3.85% |
| 2019 | -74.68 Billion JPY | -1.72% |
| 2018 | -73.42 Billion JPY | -14.34% |
| 2017 | -64.21 Billion JPY | -11.87% |
| 2016 | -57.4 Billion JPY | 5.22% |
| 2015 | -60.56 Billion JPY | -4.75% |
| 2014 | -57.81 Billion JPY | -13.42% |
| 2013 | -50.97 Billion JPY | -12.2% |
| 2012 | -45.43 Billion JPY | -8.29% |
| 2011 | -41.95 Billion JPY | -37.1% |
| 2010 | -30.6 Billion JPY | -5.35% |
| 2009 | -29.04 Billion JPY | -45.1% |
| 2008 | -20.02 Billion JPY | -21.79% |
| 2007 | -16.43 Billion JPY | -11.98% |
| 2006 | -14.67 Billion JPY | 35.63% |
| 2005 | -22.8 Billion JPY | -42.51% |
| 2004 | -16 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -50.92 Billion JPY | 17.15% |
| 2024 Q1 | -61.45 Billion JPY | 12.89% |
| 2023 Q2 | -90.3 Billion JPY | 1.96% |
| 2023 Q1 | -92.1 Billion JPY | 3.49% |
| 2023 Q4 | -70.54 Billion JPY | 18.26% |
| 2023 Q3 | -86.3 Billion JPY | 4.43% |
| 2023 FY | -70.54 Billion JPY | 26.08% |
| 2022 Q1 | -96.92 Billion JPY | -2.68% |
| 2022 FY | -95.44 Billion JPY | -1.11% |
| 2022 Q4 | -95.44 Billion JPY | 1.01% |
| 2022 Q3 | -96.41 Billion JPY | 10.02% |
| 2022 Q2 | -107.15 Billion JPY | -10.55% |
| 2021 Q2 | -84.5 Billion JPY | -3.35% |
| 2021 Q3 | -84.23 Billion JPY | 0.33% |
| 2021 Q4 | -94.39 Billion JPY | -12.07% |
| 2021 FY | -94.39 Billion JPY | -21.7% |
| 2021 Q1 | -81.77 Billion JPY | -5.42% |
| 2020 FY | -77.56 Billion JPY | -3.85% |
| 2020 Q2 | -82.75 Billion JPY | -5.32% |
| 2020 Q3 | -81.95 Billion JPY | 0.96% |
| 2020 Q4 | -77.56 Billion JPY | 5.36% |
| 2020 Q1 | -78.57 Billion JPY | -5.2% |
| 2019 Q3 | -63.43 Billion JPY | 4.54% |
| 2019 Q4 | -74.68 Billion JPY | -17.74% |
| 2019 Q1 | -70.67 Billion JPY | 3.74% |
| 2019 FY | -74.68 Billion JPY | -1.72% |
| 2019 Q2 | -66.45 Billion JPY | 5.98% |
| 2018 Q4 | -73.42 Billion JPY | -17.93% |
| 2018 Q3 | -62.25 Billion JPY | 2.98% |
| 2018 Q2 | -64.17 Billion JPY | 4.0% |
| 2018 FY | -73.42 Billion JPY | -14.34% |
| 2018 Q1 | -66.84 Billion JPY | -4.1% |
| 2017 FY | -64.21 Billion JPY | -11.87% |
| 2017 Q4 | -64.21 Billion JPY | -24.59% |
| 2017 Q3 | -51.54 Billion JPY | 3.93% |
| 2017 Q2 | -53.64 Billion JPY | 9.91% |
| 2017 Q1 | -59.54 Billion JPY | 0.0% |
| 2016 Q2 | -59.06 Billion JPY | 2.48% |
| 2016 FY | -57.4 Billion JPY | 5.22% |
| 2016 Q3 | -56.51 Billion JPY | 4.32% |
| 2016 Q1 | -60.56 Billion JPY | -8.86% |
| 2015 Q1 | -57.81 Billion JPY | -19.99% |
| 2015 Q2 | -55.81 Billion JPY | 3.46% |
| 2015 Q3 | -58.23 Billion JPY | -4.34% |
| 2015 Q4 | -55.63 Billion JPY | 4.47% |
| 2015 FY | -60.56 Billion JPY | -4.75% |
| 2014 FY | -57.81 Billion JPY | -13.42% |
| 2014 Q4 | -48.18 Billion JPY | -0.23% |
| 2014 Q3 | -48.07 Billion JPY | -2.35% |
| 2014 Q2 | -46.96 Billion JPY | 7.86% |
| 2014 Q1 | -50.97 Billion JPY | -18.07% |
| 2013 Q1 | -45.43 Billion JPY | -23.32% |
| 2013 FY | -50.97 Billion JPY | -12.2% |
| 2013 Q4 | -43.17 Billion JPY | -2.95% |
| 2013 Q3 | -41.93 Billion JPY | -3.48% |
| 2013 Q2 | -40.52 Billion JPY | 10.8% |
| 2012 Q4 | -36.84 Billion JPY | -22.18% |
| 2012 Q3 | -30.15 Billion JPY | 24.34% |
| 2012 Q2 | -39.85 Billion JPY | 5.01% |
| 2012 FY | -45.43 Billion JPY | -8.29% |
| 2012 Q1 | -41.95 Billion JPY | -21.84% |
| 2011 Q2 | -30.49 Billion JPY | 0.34% |
| 2011 Q4 | -34.43 Billion JPY | -7.65% |
| 2011 FY | -41.95 Billion JPY | -37.1% |
| 2011 Q3 | -31.98 Billion JPY | -4.88% |
| 2011 Q1 | -30.6 Billion JPY | -11.6% |
| 2010 Q4 | -27.42 Billion JPY | 0.67% |
| 2010 Q1 | -29.04 Billion JPY | -28.59% |
| 2010 Q3 | -27.6 Billion JPY | -3.21% |
| 2010 FY | -30.6 Billion JPY | -5.35% |
| 2010 Q2 | -26.74 Billion JPY | 7.92% |
| 2009 Q1 | -20.02 Billion JPY | 0.0% |
| 2009 Q4 | -22.59 Billion JPY | -9.37% |
| 2009 Q3 | -20.65 Billion JPY | 0.0% |
| 2009 FY | -29.04 Billion JPY | -45.1% |
| 2008 FY | -20.02 Billion JPY | -21.79% |
| 2007 FY | -16.43 Billion JPY | -11.98% |
| 2006 FY | -14.67 Billion JPY | 35.63% |
| 2005 FY | -22.8 Billion JPY | -42.51% |
| 2004 FY | -16 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | Infinity% |
| Bemax Inc. | 365.03 Thousand USD | 19326739.911% |
| Bruush Oral Care Inc. | -72.92 Thousand USD | -96747064.74% |
| CCA Industries, Inc. | -704.15 Thousand USD | -10018801.981% |
| DSwiss, Inc. | -212.1 Thousand USD | -33261099.589% |
| EOS, Inc. | 108.26 Thousand USD | 65166366.396% |
| Greyson International, Inc. | 59.43 Thousand USD | 118701516.698% |
| Happy Town Holdings Inc. | - USD | Infinity% |
| Horrison Resources Inc. | - USD | Infinity% |
| Infusion Brands International, Inc. | 456.63 Thousand USD | 15449992.802% |
| Mandom Corporation | -142.15 Million USD | -49527.8% |
| Naples Soap Company Inc. | - USD | Infinity% |
| Emo Capital Corp. | 17.29 Thousand USD | 407939269.654% |
| Oliveda International, Inc. | -22.67 Thousand USD | -311144823.701% |
| PacificHealth Laboratories, Inc. | -688.72 Thousand USD | -10243320.814% |
| Prosperous Future Holdings Limited | -49.42 Million USD | -142642.956% |
| PURE Bioscience, Inc. | 2.6 Million USD | 2713523.077% |
| PayChest, Inc. | - USD | Infinity% |
| Skinvisible, Inc. | 6.15 Million USD | 1146824.831% |
| Sentient Brands Holdings Inc. | 1.39 Million USD | 5072141.261% |
| Sunset Capital Assets, Inc. | 64.55 Thousand USD | 109281820.03% |
| The Stephan Co. | 510 Thousand USD | 13833237.255% |
| Turner Valley Oil & Gas, Inc. | 166.66 Thousand USD | 42330431.267% |
| Winning Brands Corporation | 2.88 Million USD | 2443530.577% |
| Warpaint London PLC | -4.58 Million USD | -1537621.128% |
| Zoono Group Limited | 202.36 Thousand USD | 34863215.24% |
| Zurvita Holdings, Inc. | 618.75 Thousand USD | 11401921.731% |